Difference between revisions of "Eluvixtamab (AMG-330)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Immunotherapy" to "Category:Immunotherapeutic") |
Warner-admin (talk | contribs) m (Text replacement - "Category:Chemotherapeutic" to "") Tags: mobile edit mobile web edit |
||
Line 3: | Line 3: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
− | + | ||
[[Category:Immunotherapeutic]] | [[Category:Immunotherapeutic]] | ||
Revision as of 22:24, 7 December 2019
Mechanism of action
Bispecific T-cell engager (BiTE) antibody that engages CD33 and CD3